Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 11128

1.

Estrogen enhances tumor growth and angiogenesis indirectly via mediation of bone marrow‑derived cells as well as directly through stimulation of tumor and endothelial cells.

Zhuo Y, Li X, Zheng Q, Fan X, Ma W, Chen J, Zhao X, Zhao P, Liu X, Tang F, Cheng K, Feng W.

Oncol Rep. 2018 Oct;40(4):2147-2156. doi: 10.3892/or.2018.6631. Epub 2018 Aug 7.

PMID:
30106454
2.

Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells.

Zhuang X, Li X, Zhang J, Hu Y, Hu B, Shi Y, Sun Y, Hong G.

Oncol Rep. 2018 Oct;40(4):2334-2342. doi: 10.3892/or.2018.6637. Epub 2018 Aug 7.

PMID:
30106453
3.

Integrin β4 reduces DNA damage‑induced p53 activation in colorectal cancer.

Wu J, Zhao R, Lin J, Liu B.

Oncol Rep. 2018 Oct;40(4):2183-2192. doi: 10.3892/or.2018.6628. Epub 2018 Aug 6.

PMID:
30106452
4.

Association between Tim‑3 and Gal‑9 expression and gastric cancer prognosis.

Wang Y, Zhao E, Zhang Z, Zhao G, Cao H.

Oncol Rep. 2018 Oct;40(4):2115-2126. doi: 10.3892/or.2018.6627. Epub 2018 Aug 6.

PMID:
30106451
5.
6.

Inhibitor of apoptosis protein‑like protein‑2: A novel growth accelerator for breast cancer cells.

Zhu L, Zhou W, Zhu X, Xiang S, Wang S, Peng Y, Lu B, Tang P, Chen Q, Wu M, Peng X, Chen Z, Sun Z, Yang K, Xiang M, Yu D.

Oncol Rep. 2018 Oct;40(4):2047-2055. doi: 10.3892/or.2018.6626. Epub 2018 Aug 3.

PMID:
30106449
7.

MicroRNA‑181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A.

Yu J, Qi J, Sun X, Wang W, Wei G, Wu Y, Gao Q, Zheng J.

Oncol Rep. 2018 Oct;40(4):1959-1970. doi: 10.3892/or.2018.6632. Epub 2018 Aug 7.

PMID:
30106448
8.

Long non‑coding RNAs in small cell lung cancer: A potential opening to combat the disease (Review).

Li TT, He RQ, Ma J, Li ZY, Hu XH, Chen G.

Oncol Rep. 2018 Oct;40(4):1831-1842. doi: 10.3892/or.2018.6635. Epub 2018 Aug 7.

PMID:
30106447
9.

Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling.

Zhang G, Fang T, Chang M, Li J, Hong Q, Bai C, Zhou J.

Oncol Rep. 2018 Oct;40(4):1937-1946. doi: 10.3892/or.2018.6625. Epub 2018 Aug 2.

PMID:
30106446
10.

miR‑590‑5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.

Mou K, Ding M, Han D, Zhou Y, Mu X, Liu W, Wang L.

Oncol Rep. 2018 Oct;40(4):2056-2066. doi: 10.3892/or.2018.6633. Epub 2018 Aug 7.

PMID:
30106445
11.

Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells.

Liu BS, Xia HW, Zhou S, Liu Q, Tang QL, Bi NX, Zhou JT, Gong QY, Nie YZ, Bi F.

Oncol Rep. 2018 Oct;40(4):2171-2182. doi: 10.3892/or.2018.6630. Epub 2018 Aug 7.

PMID:
30106444
12.

Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2.

Jin ZQ, Hao J, Yang X, He JH, Liang J, Yuan JW, Mao Y, Liu D, Cao R, Wu XZ, Li X, Chen D.

Oncol Rep. 2018 Oct;40(4):2127-2136. doi: 10.3892/or.2018.6629. Epub 2018 Aug 6.

PMID:
30106443
13.

MicroRNA‑874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.

Liao H, Pan Y, Pan Y, Shen J, Qi Q, Zhong L, Han W, Wang Q, Jiang Y.

Oncol Rep. 2018 Oct;40(4):2389-2398. doi: 10.3892/or.2018.6624. Epub 2018 Aug 2.

PMID:
30106442
14.

Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathway.

Qiao P, Li S, Zhang H, Yao L, Wang F.

Oncol Rep. 2018 Oct;40(4):2067-2078. doi: 10.3892/or.2018.6636. Epub 2018 Aug 7.

PMID:
30106441
15.

SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.

Gu Y, Wang X, Liu H, Li G, Yu W, Ma Q.

Oncol Rep. 2018 Oct;40(4):1863-1874. doi: 10.3892/or.2018.6621. Epub 2018 Aug 2.

PMID:
30106440
16.

Zinc enhances chemosensitivity to paclitaxel in PC‑3 prostate cancer cells.

Zhang P, Li Y, Tang X, Guo R, Li J, Chen YY, Guo H, Su J, Sun L, Liu Y.

Oncol Rep. 2018 Oct;40(4):2269-2277. doi: 10.3892/or.2018.6622. Epub 2018 Aug 2.

PMID:
30106439
17.

Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspase‑dependent pathway.

Dong X, Ni B, Fu J, Yin X, You L, Leng X, Liang X, Ni J.

Oncol Rep. 2018 Oct;40(4):1985-1993. doi: 10.3892/or.2018.6620. Epub 2018 Aug 2.

PMID:
30106438
18.

Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.

Shi Y, Chen Z, Gao J, Wu S, Gao H, Feng G.

Oncol Rep. 2018 Oct;40(4):2014-2022. doi: 10.3892/or.2018.6623. Epub 2018 Aug 2.

PMID:
30106437
19.

Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.

Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Lirdprapamongkol K, Srisomsap C, Svasti J, Champattanachai V.

Oncol Rep. 2018 Oct;40(4):2193-2205. doi: 10.3892/or.2018.6617. Epub 2018 Aug 1.

PMID:
30106436
20.

Sonodynamic therapy improves anti‑tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.

Peng Y, Jia L, Wang S, Cao W, Zheng J.

Oncol Rep. 2018 Oct;40(4):2163-2170. doi: 10.3892/or.2018.6612. Epub 2018 Aug 1.

PMID:
30106435

Supplemental Content

Loading ...
Support Center